Earnings Will Shape the Market Psychology<br />By Rev Shark<br />RealMoney.com Contributor<br />10/15/2007 7:57 AM EDT <br /><br /><br />Life is so constructed that an event does not, cannot, will not, match the expectation. <br />-- Charlotte Bronte<br /><br />As third-quarter earnings season starts this week, the overall market mood continues to be quite positive and upbeat. The sharp dip back in August due to credit and subprime issues has been forgotten as the market has taken comfort in the fact that the Fed was so willing to cut interest rates and to take whatever steps were necessary to ease the liquidity issues that erupted. <br /><br />Although the chances of further rate cuts have declined recently, the market hasn't been overly concerned about it. There seems to be a good amount of optimism about the strength of the economy, and that is keeping stocks strong now, although it was an interest rate cut that was the primary catalyst for the strong move off the August low. <br /><br />In other words, all news has been good news. When there was negative news, the market has treated it as positive, as it was confident that we would see more rate cuts and a friendly Fed. When there was positive news, interest rates became less important as investors took comfort in economic strength and have been focusing on how the strength in the international economy would help the U.S. deal with its real estate problems and economic slowdown. <br /><br />That sets the stage for earnings reports, which start in earnest this week with companies such as Intel (INTC) , IBM (IBM) , Yahoo! (YHOO) and Google (GOOG) reporting. <br /><br />The issue we need to contemplate this week is the market psychology. Will market players continue to view all news as good news? Will we forgive weak guidance because we are counting on the Fed to provide more interest rate cuts? Are strong reports already priced in because of the move we have enjoyed in recent weeks? Are market players in a "buy the news" or a "sell the news" mood? <br /><br />The biggest problem for the market at this point is that the indices have had such a strong run recently. We are up big since the August low, and that increases the danger that profit-taking will occur if reports aren't good and guidance strong. The market has a high level of expectations, and that means it won't take much for selling to kick in should there be any deficiencies in the upcoming reports. <br /><br />During the last couple of quarters, the market has generally had a positive reaction to earnings even though we had technical setups that were favorable for a "sell the news" reaction. Market players stayed optimistic. Even though expectations were high, reports were good enough to prevent any major selling reaction. <br /><br />This quarter, it is widely expected that an economic slowdown will start hitting earnings in the next six months or so, and it will be very interesting to see whether companies use that to their advantage by lowering expectations now so that they can exceed them in the future. The market has been quite forgiving of that game in the past. <br /><br />At this point, we simply have to wait and see how the market handles reports. Intel and Yahoo on Tuesday night will be the first big test, and Google on Thursday is likely to be extremely important in determining our mood. <br /><br />For now, all is good and the uptrend is intact, but earnings can change things quickly. Be ready to make some moves. <br /><br />We have a flat start shaping up this morning. Overseas markets were mixed, and there isn't much news on the wires so far. <br />----------------------------<br />Ülespoole avanevad:<br /><br />On strong earnings/guidance: ANTP +24.2%, XSI +17.2%, EDU +7.8%... M&A- related: TEK +33.0% (to be acquired by DHR for $38/share), BIIB +19.5% (co says it has received expressions of interest from third parties and it will evaluate potential interest in acquiring the co -- ELN +11.1% and PDLI +3.9% gapping up in sympathy)... Other news: TELK +30.0% (FDA removes partial hold on TELCYTA clinical development), BRLC (announces introduction of full-HD 1080p Olevia brand LCD HDTVs), PTR +11.7% (Reuters reports PTR jumped 13% as news of increased production and hopes of major new discoveries spurred optimism about its performance in Q4), SNP +11.5% (upgraded to Buy at Citigroup), TTG +11.3% (positive Cramer mention), ELN +11.1% (in addition to the BIIB evaluation of M&A interest, BIIB and ELN announced that the FDA has extended its regulatory review of Tysabri as a treatment for Crohn's disease by up to 3 months), TSTC +10.4% (announces positive response from China Mobile on WFDS field tests), FTEK +10.2% (mentioned positively in Barron's), CSUN +4.3%, CHL +4.2%. <br /><br />Allapoole avanevad:<br /><br />On weak earnings/guidance: ETN -4.7%... Other news: MDT -5.0% (voluntarily suspends distribution of Sprint Fidelis defibrillation leads), FRPT -8.1% (discloses certain material weaknesses), CTEL -5.0% (says not aware of any reasons for such decrease in the price and increase in the trading volume), PHG -4.6% (3Q earnings fall on semiconductor unit sale, says operations grow - International Herald Tribune), LVLT -4.3% (announced that it is beginning a search for a new CFO), HSWI -3.0% (major shareholder, HowStuffWorks, enters into merger agreement with Discovery Communications).